MCRB
Seres Therapeutics Inc
2.90$
+0.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | – | – | – | 100.0% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 185.5% | 667.2% | 668.1% | 765.1% | 96.5% | 786.7% | 590.8% | 521.5% | 261.5% | 233.0% | 312.6% | 142.9% | 260.5% | 275.9% | 265.5% | 332.5% | 1,683.9% | 141.6% | 512.5% | 683.1% | 31.5% | 509.0% | 2,655.7% | 3,613.1% | 1,251.9% | 4,740.5% | – | 37.0% | 1,530.3% | 6,332.8% | – | – | – | 86.1% | – | – | 3,804.0% | -3,151.8% | 218.2% | 0.0% | 17.4% | |
| -85.5% | -567.2% | -568.1% | -665.1% | 3.5% | -686.7% | -490.8% | -421.5% | -161.5% | -133.0% | -212.6% | -42.9% | -160.5% | -175.9% | 100.0% | 100.0% | 100.0% | -41.6% | -412.5% | -583.1% | 68.5% | -409.0% | -2,555.7% | -3,513.1% | -1,151.9% | -4,640.5% | – | 63.0% | -1,530.3% | 100.0% | – | – | – | -86.1% | – | – | -3,704.0% | 3,251.8% | -118.2% | 100.0% | 82.6% | |
| 185.5% | 667.2% | 668.1% | 765.1% | 96.5% | 786.7% | 590.8% | 521.5% | 261.5% | 233.0% | 312.6% | 142.9% | 260.5% | 275.9% | 265.5% | 332.5% | 1,683.9% | 141.6% | 512.5% | 683.1% | 31.5% | 509.0% | 2,655.7% | 3,613.1% | 1,251.9% | 4,740.5% | – | 37.0% | 8,114.2% | 41,946.9% | – | – | – | 215.5% | – | – | 3,594.3% | 2,667.6% | 3,685.8% | 1,242.0% | 2,476.7% | |
| 61.2% | 278.4% | 290.6% | 277.7% | 35.3% | 287.6% | 221.0% | 188.5% | 83.8% | 70.9% | 102.4% | 44.5% | 83.9% | 75.9% | 75.0% | 107.4% | 532.9% | 60.3% | 205.3% | 331.6% | 15.4% | 284.0% | 1,243.9% | 1,672.3% | 533.8% | 2,297.8% | – | 22.2% | 6,268.4% | 26,928.1% | – | – | – | 209.2% | – | – | 2,699.7% | 1,721.2% | 2,254.2% | 959.4% | 1,707.2% | |
| 246.7% | 945.6% | 958.7% | 1,042.8% | 131.8% | 1,074.3% | 811.8% | 710.1% | 345.3% | 303.9% | 415.0% | 187.4% | 344.4% | 75.9% | 340.5% | 439.9% | 2,216.8% | 60.3% | 205.3% | 331.6% | 14.5% | 275.6% | 1,178.5% | 1,694.6% | 564.3% | 2,365.3% | – | 23.8% | 12,852.3% | 61,859.4% | – | – | – | 397.9% | – | – | 2,699.7% | 7,675.8% | 5,721.8% | 2,990.4% | 4,545.4% | |
| -146.7% | -845.6% | -858.7% | -942.8% | -31.8% | -974.3% | -711.8% | -610.1% | -245.3% | -203.9% | -335.4% | -87.4% | -244.4% | -251.8% | -240.5% | -339.9% | -2,116.8% | -101.9% | -617.8% | -914.7% | 54.0% | -684.6% | -3,734.2% | -5,207.6% | -1,716.2% | -7,005.8% | – | 39.2% | -14,382.6% | -61,759.4% | – | – | – | -484.0% | – | – | -6,403.7% | -4,424.0% | -5,839.9% | -2,890.4% | -4,462.8% | |
| 2.4% | 11.5% | 11.9% | 0.0% | 0.5% | 52.0% | 8.7% | 0.0% | 2.9% | 11.0% | 3.0% | 1.5% | 4.8% | 6.6% | 8.7% | 11.9% | 51.5% | 4.3% | 12.2% | 13.9% | 0.6% | 10.2% | 61.1% | 123.4% | 50.1% | 192.8% | – | 2.5% | 1,294.2% | 6,295.3% | – | – | – | 0.0% | – | – | – | – | – | – | – | |
| -143.6% | -832.5% | -844.9% | -929.6% | -30.1% | -947.4% | -703.1% | -602.5% | -242.4% | -200.3% | -332.4% | -85.9% | -233.4% | -246.4% | -242.8% | -342.7% | -2,136.9% | -103.9% | -620.2% | -918.3% | 53.8% | -692.4% | -3,792.6% | -5,323.6% | -1,742.2% | -7,056.0% | – | 36.8% | -13,230.6% | -64,450.0% | – | – | – | -262.5% | – | – | 2,337.3% | -3,501.1% | -5,562.3% | 622.4% | -1,192.9% | |
| 5.5% | 24.6% | -83.1% | -20.4% | -2.2% | 9.9% | 0.0% | 0.0% | 0.0% | 0.0% | 17.4% | – | -4.8% | -12.9% | 13.2% | 19.8% | 75.9% | 3.1% | 5.0% | 8.5% | 0.6% | -70.4% | 58.5% | 98.4% | 49.2% | 50.2% | – | 0.1% | 464.5% | -3,429.7% | – | – | – | – | – | – | – | – | – | – | – | |
| -143.6% | -832.5% | -844.9% | -929.6% | -30.1% | -947.4% | -703.1% | -602.5% | -242.4% | -200.3% | -332.4% | -85.9% | -233.4% | -246.4% | -242.8% | -342.7% | -2,136.9% | -103.9% | -620.2% | -918.3% | 53.8% | -692.4% | -3,792.6% | -5,323.6% | -1,742.2% | -7,056.0% | – | 36.8% | -15,436.8% | -64,450.0% | – | – | – | -262.5% | – | – | 2,337.3% | -3,501.1% | -5,562.3% | 622.4% | -1,192.9% | |
| -137.1% | -776.7% | -801.3% | -884.4% | -23.7% | -912.0% | -662.9% | -567.7% | -223.5% | -185.1% | -297.7% | -74.8% | -206.7% | -228.2% | -212.0% | -302.8% | -1,974.2% | -93.3% | -592.0% | -877.3% | 55.6% | -660.7% | -3,626.4% | -5,061.6% | -1,641.3% | -6,696.3% | – | 40.5% | -12,687.4% | -55,604.7% | – | – | – | -244.2% | – | – | 2,639.0% | -3,013.7% | -5,344.1% | -2,890.4% | -2,354.9% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.